Post

India's Parry Nutraceuticals Gets USFDA Approval

India's Parry Nutraceuticals Gets USFDA Approval

Based in India’s southern state of Tamil Nadu, Parry Nutraceuticals received the U.S. Food and Drug Administration approval for its India facility for organic micro-algae cultivation and processing.

Business head, Parry Nutraceuticals, Muthu Murugappan said that some of the products that they planned to bring to market over the next two years include Organic Chlorella, Spirulina Granules, CO2 Extracted Lutein and Algal Beta Glucan. New areas currently under development include vegan algal proteins, chlorophyll and algae  omega-3s, reports Outlook.

Parry Nutraceuticals Logo

Valensa International, based in Florida, which specializes in the development of condition-specific nutraceuticals such as joint, eye and cardio-vascular health issues, is a wholly owned subsidiary of Parry.

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries